Page 48 - TD-4-2

Tumor Discovery Understanding glioblastoma invasion and therapy

with standard radiation and temozolomide in patients with doi: 10.1016/j.ccell.2017.02.009
newly diagnosed glioblastoma: A multicenter phase II trial. 157. Minchinton AI, Tannock IF. Drug penetration in solid
J Clin Oncol. 2009;27(25):4155-4161.
tumours. Nat Rev Cancer. 2006;6(8):583-592.
doi: 10.1200/JCO.2008.21.6895 doi: 10.1038/nrc1893
146. Izumoto S, Miyauchi M, Tasaki T, et al. Seizures and tumor 158. Sampson JH, Gunn MD, Fecci PE, Ashley DM. Brain
progression in glioma patients with uncontrollable epilepsy immunology and immunotherapy in brain tumours. Nat
treated with perampanel. Anticancer Res. 2018;38(7): Rev Cancer. 2020;20(1):12-25.
4361-4366.
doi: 10.1038/s41568-019-0224-7
doi: 10.21873/anticanres.12737
159. Ousman SS, Kubes P. Immune surveillance in the central
147. Weil S, Osswald M, Solecki G, et al. Tumor microtubes nervous system. Nat Neurosci. 2012;15(8):1096-1101.
convey resistance to surgical lesions and chemotherapy in
gliomas. Neuro Oncol. 2017;19(10):1316-1326. doi: 10.1038/nn.3161
doi: 10.1093/neuonc/nox070 160. Vitkovic L, Maeda S, Sternberg E. Anti‑inflammatory
cytokines: Expression and action in the brain.
148. Tombal B, Denmeade SR, Gillis JM, Isaacs JT. A Neuroimmunomodulation. 2001;9(6):295-312.
supramicromolar elevation of intracellular free calcium
([Ca(2 )](i)) is consistently required to induce the execution doi: 10.1159/000059387
+
phase of apoptosis. Cell Death Differ. 2002;9(5):561-573. 161. Graeber MB, Scheithauer BW, Kreutzberg GW. Microglia in
doi: 10.1038/sj.cdd.4400999 brain tumors. Glia. 2002;40(2):252-259.
149. Brightman MW, Reese TS. Junctions between intimately doi: 10.1002/glia.10147
apposed cell membranes in the vertebrate brain. J Cell Biol. 162. Hussain SF, Yang D, Suki D, Aldape K, Grimm E,
1969;40(3):648-677. Heimberger AB. The role of human glioma-infiltrating
doi: 10.1083/jcb.40.3.648 microglia/macrophages in mediating antitumor immune
responses. Neuro Oncol. 2006;8(3):261-279.
150. Sarkaria JN, Hu LS, Parney IF, et al. Is the blood-brain barrier
really disrupted in all glioblastomas? A critical assessment of doi: 10.1215/15228517-2006-008
existing clinical data. Neuro Oncol. 2018;20(2):184-191. 163. Zhang I, Alizadeh D, Liang J, et al. Characterization of
doi: 10.1093/neuonc/nox175 arginase expression in glioma-associated microglia and
macrophages. PLoS One. 2016;11(12):e0165118.
151. Daneman R, Prat A. The blood-brain barrier. Cold Spring
Harbor Perspect Biol. 2015;7(1):a020412. doi: 10.1371/journal.pone.0165118
doi: 10.1101/cshperspect.a020412 164. Wainwright DA, Balyasnikova IV, Chang AL, et al. IDO
expression in brain tumors increases the recruitment of
152. Löscher W, Potschka H. Blood-brain barrier active efflux regulatory T cells and negatively impacts survival. Clin
transporters: ATP-binding cassette gene family. NeuroRx. Cancer Res. 2012;18(22):6110-6121.
2005;2(1):86-98.
doi: 10.1158/1078-0432.Ccr-12-2130
doi: 10.1602/neurorx.2.1.86
165. Uyttenhove C, Pilotte L, Théate I, et al. Evidence for
153. Armulik A, Genové G, Betsholtz C. Pericytes: Developmental, a tumoral immune resistance mechanism based on
physiological, and pathological perspectives, problems, and tryptophan degradation by indoleamine 2,3-dioxygenase.
promises. Dev Cell. 2011;21(2):193-215. Nat Med. 2003;9(10):1269-1274.
doi: 10.1016/j.devcel.2011.07.001 doi: 10.1038/nm934
154. Hall CN, Reynell C, Gesslein B, et al. Capillary pericytes 166. Woroniecka K, Fecci PE. T-cell exhaustion in glioblastoma.
regulate cerebral blood flow in health and disease. Nature. Oncotarget. 2018;9(82):35287-35288.
2014;508(7494):55-60.
doi: 10.18632/oncotarget.26228
doi: 10.1038/nature13165
167. Chongsathidkiet P, Jackson C, Koyama S, et al. Sequestration
155. Abbott NJ, Rönnbäck L, Hansson E. Astrocyte-endothelial of T cells in bone marrow in the setting of glioblastoma and
interactions at the blood-brain barrier. Nat Rev Neurosci. other intracranial tumors. Nat Med. 2018;24(9):1459-1468.
2006;7(1):41-53.
doi: 10.1038/s41591-018-0135-2
doi: 10.1038/nrn1824
168. Fecci PE, Mitchell DA, Whitesides JF, et al. Increased
156. Quail DF, Joyce JA. The microenvironmental landscape of regulatory T-cell fraction amidst a diminished CD4
brain tumors. Cancer Cell. 2017;31(3):326-341. compartment explains cellular immune defects in patients

Volume 4 Issue 2 (2025) 40 doi: 10.36922/td.8578